Illumina

Illumina dominates the DNA sequencing market with technologies that have reduced the cost of sequencing a human genome from billions of dollars to under $1,000. The company's platforms power genomic research worldwide, enabling precision medicine, agricultural genomics, and microbiology applications. Illumina's technology democratized access to genomic information and accelerated biological discovery.